Understanding how brain function relates to substance use in teenagers
Neurocognitive Fingerprints of Substance Use and Misuse in Adolescents
This study is looking at how certain brain functions and decision-making skills can affect substance use in teens aged 12 to 20, helping us understand why some young people might be more at risk for using alcohol and drugs.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10698046 on NIH RePORTER |
What this research studies
This research investigates the neurocognitive factors that influence substance use and misuse among adolescents aged 12 to 20. By analyzing data from the Adolescent Brain Cognitive Development Study, the research aims to identify specific brain functions and decision-making processes that may predict risky behaviors related to alcohol and drug use. The study combines neuroimaging and behavioral data to create 'neurocognitive fingerprints' that can help in understanding individual vulnerabilities to substance misuse. This approach seeks to provide insights into how cognitive control and emotional sensitivity affect substance use behaviors during critical developmental years.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who may be experiencing or are at risk for substance use or misuse.
Not a fit: Patients outside the age range of 12 to 20 or those who do not engage in substance use behaviors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that help prevent substance misuse in adolescents by identifying at-risk individuals based on their neurocognitive profiles.
How similar studies have performed: Previous research has shown promise in linking neurocognitive factors to substance use behaviors, suggesting that this approach could yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Baskin-Sommers, Arielle Ryan — Yale University
- Study coordinator: Baskin-Sommers, Arielle Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.